Herman EH - Search Results

1

Effect of pretreatment with ICRF-187 on the total cumulative dose of doxorubicin tolerated by beagle dogs.

Herman EH, Ferrans VJ, Young RS, Hamlin RL. Herman EH, et al. Cancer Res. 1988 Dec 1;48(23):6918-25. Cancer Res. 1988. PMID: 3141049

2

Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation.

Herman EH, Rahman A, Ferrans VJ, Vick JA, Schein PS. Herman EH, et al. Cancer Res. 1983 Nov;43(11):5427-32. Cancer Res. 1983. PMID: 6616474

3

Reduction of chronic doxorubicin cardiotoxicity in dogs by pretreatment with (+/-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187).

Herman EH, Ferrans VJ. Herman EH, et al. Cancer Res. 1981 Sep;41(9 Pt 1):3436-40. Cancer Res. 1981. PMID: 6790165

4

Effects of ICRF-186 [(L)1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] on the toxicity of doxorubicin in spontaneously hypertensive rats.

Zhang J, Herman EH, Ferrans VJ. Zhang J, et al. Among authors: herman eh. Toxicology. 1994 Sep 6;92(1-3):179-92. doi: 10.1016/0300-483x(94)90176-7. Toxicology. 1994. PMID: 7940559

5

Comparison of the protective effects of desferrioxamine and ICRF-187 against doxorubicin-induced toxicity in spontaneously hypertensive rats.

Herman EH, Zhang J, Ferrans VJ. Herman EH, et al. Cancer Chemother Pharmacol. 1994;35(2):93-100. doi: 10.1007/BF00686629. Cancer Chemother Pharmacol. 1994. PMID: 7987999

6

Timing of treatment with ICRF-187 and its effect on chronic doxorubicin cardiotoxicity.

Herman EH, Ferrans VJ. Herman EH, et al. Cancer Chemother Pharmacol. 1993;32(6):445-9. doi: 10.1007/BF00685888. Cancer Chemother Pharmacol. 1993. PMID: 8258192

7

Dendritic cells in the hearts of spontaneously hypertensive rats treated with doxorubicin with or without ICRF-187.

Zhang J, Herman EH, Ferrans VJ. Zhang J, et al. Among authors: herman eh. Am J Pathol. 1993 Jun;142(6):1916-26. Am J Pathol. 1993. PMID: 8506959 Free PMC article.

8

Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187.

Zhang J, Clark JR Jr, Herman EH, Ferrans VJ. Zhang J, et al. Among authors: herman eh. J Mol Cell Cardiol. 1996 Sep;28(9):1931-43. doi: 10.1006/jmcc.1996.0186. J Mol Cell Cardiol. 1996. PMID: 8899552

9

Comparison of the protective effects against chronic doxorubicin cardiotoxicity and the rates of iron (III) displacement reactions of ICRF-187 and other bisdiketopiperazines.

Herman EH, Zhang J, Hasinoff BB, Chadwick DP, Clark JR Jr, Ferrans VJ. Herman EH, et al. Cancer Chemother Pharmacol. 1997;40(5):400-8. doi: 10.1007/s002800050677. Cancer Chemother Pharmacol. 1997. PMID: 9272116

10

Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity.

Herman EH, Lipshultz SE, Rifai N, Zhang J, Papoian T, Yu ZX, Takeda K, Ferrans VJ. Herman EH, et al. Cancer Res. 1998 Jan 15;58(2):195-7. Cancer Res. 1998. PMID: 9443390

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters